key: cord-0960342-43g3yk93
authors: Saleh, Qais W.; Grønbæk, Lone; Kronborg, Christian; Lauridsen, Jørgen T.; Tepel, Martin
title: Kidney function, future health costs, and quality-adjusted life-years in kidney transplant recipients transplanted during the SARS-Cov-2 lockdown in Denmark – an observational study
date: 2021-11-26
journal: Heliyon
DOI: 10.1016/j.heliyon.2021.e08489
sha: c0b6c622d9ac12699a8b70063e8d6b96be08094b
doc_id: 960342
cord_uid: 43g3yk93

BACKGROUND: It is unknown whether lockdown due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect both clinical outcome in kidney transplant recipients and health care economics in Denmark. METHODS: We compared kidney transplant data at a tertiary university hospital before and during the lockdown period from March 13, 2020 until March 31, 2021, as well as kidney transplant data from Scandiatransplant for entire Denmark. Outcome variables included fall of plasma creatinine during the first postoperative day, and graft function three months posttransplant. We calculated the quality-adjusted life-years (QALYs) and costs which were caused by the lockdown recommendations. FINDINGS: The portion of living donation kidney transplantation was largely reduced during the lockdown period compared to before the lockdown: AB0-incompatible living donation declined from 14% to 7% (P<0.01), and AB0-compatible living donation declined from 34% to 20% (p<0.01). In entire Denmark during the lockdown period 78 living donor kidney transplants out of 268 kidney transplants (29%) were performed, whereas there were 878 living donor kidney transplants out of 2218 kidney transplants (39%) before the lockdown (P=0.01). The observed reduction of living donor kidney transplants and consecutive reduction of graft survival will cause a loss of 5.04 QALYs. The additional costs in kidney transplant recipients who received a kidney transplant during the lockdown period will be 277,298 EUR. INTERPRETATION: SARS-CoV-2 lockdown period largely reduced living donation kidney transplants which will lead to reduced QALY as well as higher costs in kidney transplant recipients.

We compared kidney transplant data at a tertiary university hospital before and during the lockdown period from March 13, 2020 until March 31, 2021, as well as kidney transplant data from Scandiatransplant for entire Denmark. Outcome variables included fall of plasma creatinine during the first postoperative day, and graft function three months posttransplant.

We calculated the quality-adjusted life-years (QALYs) and costs which were caused by the lockdown recommendations.

The portion of living donation kidney transplantation was largely reduced during the lockdown period compared to before the lockdown: AB0-incompatible living donation declined from 14% to 7% (P<0.01), and AB0-compatible living donation declined from 34% to 20% (p<0.01).

In entire Denmark during the lockdown period 78 living donor kidney transplants out of 268 kidney transplants (29%) were performed, whereas there were 878 living donor kidney transplants out of 2218 kidney transplants (39%) before the lockdown (P=0.01).

The observed reduction of living donor kidney transplants and consecutive reduction of graft survival will cause a loss of 5.04 QALYs.

The additional costs in kidney transplant recipients who received a kidney transplant during the lockdown period will be 277,298 EUR.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has posed major challenges in every aspect of healthcare. Kidney transplant recipients (KTRs) were thought to be especially vulnerable to severe SARS-CoV-2 infections and mortality because they are immunosuppressed. Initial studies showed mortality rates ranging from 20% to 32% [1] [2] [3] , and SARS-Cov-2-associated acute kidney injury in 52% [3] . At the start of the pandemic, it was uncertain, how to practice kidney transplantation in patients with end-stage kidney disease during this challenging period [4] [5] [6] .

Denmark was one of the first countries in Europe which responded to the rise of SARS-CoV-2 cases with a lockdown that was announced to officially begin March 13, 2020 [7] . The Danish health authorities issued a statement recommending a halt to all surgical procedures that were safe to postpone [8] . Kidney transplantation with living donation was an example of a procedure deemed to be safe to postpone, while donation from deceased, brain-dead donors was not [8] .

According to lockdown recommendations, kidney transplantation was continued on tertiary university hospital (Odense University Hospital, Odense, Denmark). However, contact to kidney transplant recipients were kept to a minimum, and fast discharge was encouraged. Upon discharge, tele-communication through phone calls was the encouraged method of follow-up, and in-person consultation was undergone only if the treating specialist deemed it necessary.

The effects of the lockdown recommendations and changes of care during hospitalization and to follow-up of newly transplanted patients are unknown. Furthermore, it is unknown whether the recommendations to halt to all surgical procedures that were safe to postpone may have effects on end-stage renal failure patients on the waiting list for kidney transplantation. We therefore hypothesized that the lockdown recommendations may have affected kidney transplantations.

The objective of the present investigation was to compare the characteristics of kidney transplant recipients who were transplanted during and before the SARS-Cov-2 lockdown period at tertiary university hospital. We evaluated whether the lockdown may affect medical and clinical outcome in kidney transplant recipients. In addition, we investigated the changes to the type and number of transplants performed in entire Denmark during the lockdown period and evaluated the effects of lockdown recommendation on future quality-adjusted life-year (QALY) and health economics. [11] . In Denmark, the official nationwide lockdown started March 13, 2020 [7, 8] , which included the closure of universities, restrictions for number of people assembling in public areas, and the recommendation that all surgical procedures, which were safe to be postponed, should be avoided [8] . Most restrictions were retracted until March 31, 2021.

During the lockdown period in Denmark from March 13, 2020, until March 31, 2021, a total of 67 patients were screened for inclusion into the MoMoTx study. Seven patients were excluded from the present investigation, because three patients did not receive a transplant because of severely calcified arteries, one with missing consent, two had graftectomies shortly after transplantation, and one patient died. The present study contained 60 cases. During the control period, i.e., from January 1, 2011 until December 31, 2020, a total of 533 kidney transplant recipients were screened. Five patients were excluded from the present investigation, because four had graftectomies shortly after transplantation, and one patient died. Thus, the present study contained 60 matched controls out of 528 kidney transplant recipients.

Cases were adult kidney transplant recipients who were transplanted at the Odense University Hospital during the SARS-CoV-2 lockdown period, from March 13, 2020 until March 31, 2021. Controls were adult kidney transplant recipients who were transplanted at the Odense University Hospital in the period from January 1, 2011 until December 31, 2020. Controls were matched to cases according to donor type (i.e., AB0-blood-type-incompatible living donation, AB0-blood-type-compatible living donation, and donation after brain death), kidney transplant J o u r n a l P r e -p r o o f recipient gender, and age (within 5-year intervals). If several putative matching controls were available, we chose the most recent kidney transplant recipient.

We collected data from electronical medical record review. Data included recipient age, gender, biochemical characteristics, donor type (AB0-blood-type-incompatible living donation, AB0-blood-type-compatible living donation and donation after brain death), plasma creatinine levels on the day before and after kidney transplantation, comorbidities, cause of kidney disease, number of blood tests, and time until removal of ureteral stents which had routinely been placed during transplantation.

The outcome variables were delayed graft function, which was defined according to United Network for Organ Sharing at least one dialysis session within one week after transplantation [12] ; estimated glomerular filtration rate (eGFR) one month after transplantation, as calculated according to the Chronic Kidney Disease Epidemiology Collaboration equation [13] , bacterial infections requiring hospitalization within three months posttransplant, which was defined as the presence of relevant symptoms and biochemical -or microbiological evidence of a bacterial disease or alleviation of symptoms following use of antibiotics, urological complications posttransplant requiring hospitalization, e.g., need for ureteral stenting or nephrostomy.

The sample size was calculated to be 23 with a power of 0.80; standard deviation of eGFR one month after transplantation derived from preliminary studies, 18 mL/min/1.73m 2 ; and assuming a clinical meaningful difference of eGFR of 15 mL/min/1.73m 2 .

The MoMoTx study has been approved by the local ethics committee (Den Videnskabsetiske Komite for Region Syddanmark, Projekt-ID: 20100098), and the study protocol is in accordance with the ethical standards of the Declarations of Helsinki and Istanbul. Its registration identifier at ClinicalTrials.gov is NCT01515605. Permission for data processing was acquired from the Danish data protection agency (journal nr.: 18/18718).

Continuous data are presented as median and interquartile range (IQR). Frequency counts were calculated for categorical data. For comparative statistics in the case-control analysis, we used non-parametric Mann-Whitney U test to compare continuous data, and Fisher's exact test to compare categorical data. 

Data concerning the number of transplantations and donor type was gathered from Scandiatransplant, the organ exchange organization for the countries Denmark, Finland, Iceland, Norway, Sweden and Estonia [14] . Quarterly, Scandiatransplant publishes freely accessible data concerning organ transplantation from all transplant centers in Denmark, including Aarhus University Hospital (Aarhus), Rigshospitalet (Copenhagen) and Odense University Hospital (Odense).

The lockdown period in Denmark was defined as the second, third and fourth quarter of 2020, as well as the first quarter of 2021. We calculated the average number of kidney transplants performed per month and the ratio of living donation and donation after brain death per year, results are displayed as mean and standard deviation (SD). The yearly ratio of living donation and donation after brain death during the lockdown period in Denmark was compared to the yearly ratio obtained before the lockdown period using one-sided t-test.

We estimated the number of recipients who will require dialysis within five years post transplantation using recent patient and allograft survival data from the Danish Nephrology Society Registry Annual Report 2017 [15] both for recipients with living donation and recipients with donation after brain death and calculated costs and quality-adjusted life-year (QALY). To determine QALY, we used utility values for transplantation and hemodialysis from a Scandinavian population provided by Sennfält et al. [16] . Costs for transplantation and dialysis have been published by Jensen et. al. [17] .

The funder had no role in the writing of the manuscript or the decision to submit it for publication. The funder had no role in data collection, analysis, or interpretation; trial design; patient recruitment; or any aspect pertinent to the study. There was no payment for writing this article by a pharmaceutical company or other agency.

The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication.

J o u r n a l P r e -p r o o f

We analyzed data from 584 incident kidney transplant recipients from the ongoing, prospective MoMoTx study, 60 cases were transplanted during lockdown period from March 13, 2020, until March 31, 2021; whereas 524 controls had been transplanted before the lockdown, i.e., from January 1, 2011 until December 31, 2020. The clinical and biochemical characteristics of kidney transplant recipients are shown in Table 1 .

Age, gender, and underlying cause of kidney disease were not significantly different between kidney transplant recipients who were transplanted during and before the lockdown, which indicates that patients with end-stage kidney disease were consistent during and before lockdown. Kidney function, i.e., eGFR four weeks posttransplant, tended to be lower in kidney transplant recipients who were transplanted during compared to before the lockdown (median, 39.9 mL/min/1.73m 2 ; IQR, 28.9-52.9; vs. median, 45.3 mL/min/1.73m 2 ; IQR, 32.6-56.9; P=0.11).

Furthermore, kidney transplant recipients who received the transplant during the lockdown period had significantly lower hospital stay (median, 7 days; IQR, 7-9; vs. median 8 days; IQR, 7-12; P<0.01). Table 1 summarizes the data for comparisons.

Now, we evaluated whether the lockdown may affect medical and clinical outcome in kidney transplant recipients. Table 2 Table 3 shows that these findings could be confirmed in all three transplant groups, i.e., ABO incompatible living donation, ABO compatible living donation, and donation after brain death, supporting that the lockdown did not change medical and clinical outcome in kidney transplant recipients.

In total 268 patients received a kidney transplant during the lockdown period in Denmark, 

According to the annual report of the Danish Nephrology Registry from 2017, 5-year survival on patients transplanted with the first renal graft from 2010 to 2014 was 95% for living donor kidney transplants and 88% for donation after brain death [15] . The 5-year death censored graft survival was 93% for living donor kidney transplants and 87% for donation after brain death. [15] . Since our case-control study showed that the lockdown did not change medical and clinical outcome in kidney transplant recipients these data may be extrapolated for kidney transplant recipients who received a graft during the lockdown period. According to expected 5-year death censored graft survival, 23 kidney transplant recipients with donation after brain death, as well as 5 kidney transplant recipients with living donation who received a graft during the lockdown period will require dialysis again after five years.

In the absence of the lockdown recommendations, 161 patients could have received a kidney transplant with donation after brain death, as well as 107 patients could have received kidney transplant with living donations. According to expected 5-year death censored graft survival, 20 kidney transplant recipients with donation after brain death, as well as six kidney transplant recipients with living donation would require dialysis again after five years.

From an economic perspective the additional two patients in dialysis as a consequence of the lockdown would have implications for future cost of dialysis and future QALYs. Previous studies have reported that the total expected cost (discounted value) of dialysis per patient for 6-year period is 1,032,934 DKK using 2012 currency [17] . Hence, due to the lockdown recommendations, the additional expected cost difference would correspond to 2,065,868 DKK (277,298 EUR) after five years. Furthermore, patients in dialysis have reduced quality of life compared to transplanted patients.

The utility value has been reported to be 0.86 for kidney transplant recipients and 0.44 for patients requiring dialysis [16] . Consequently, the lockdown has caused an expected loss equivalent to 0.42 QALYs per patient per year after 5 years. In relation to the previous study of the cost-effectiveness of kidney transplantation, which used a six-year time horizon [17] , the total additional loss of QALYs would be 5.04 after five years because of the lockdown.

That is, the observed 10% reduction of kidney transplant recipients with living donation and consecutive reduction of graft survival causes 1.9% reduction of QALYs for kidney transplant recipients who received a kidney transplant during the lockdown period. These findings are illustrated in Figure 2 .

In this two-part study, we evaluated the effects of the SARS-CoV-2 lockdown recommendations on the specialized care of incident kidney transplant recipients. Firstly, we compared cases with kidney transplantations during the lockdown period with matched controls transplanted before lockdown and investigated effects on clinical and medical outcomes. Secondly, using data from the organ exchange organization Scandiatransplant, we explored the changes to the number and type of kidney transplants performed during and before lockdown, and the implications on QALY and costs.

We observed that lockdown recommendations largely reduced living donation kidney transplantation. This finding at our tertiary university hospital could be confirmed analyzing transplant data from all transplant centers in Denmark. A reduction of living donation kidney transplantation was also been reported in other countries [4] .

Living donation kidney transplantation had been classified as elective by the Danish health authorities [8] This recommendation was designed to lessen the burden on health care providers, materials such as respirators and intensive care spots and overall logistics, and to provide the possibility of resource allocation to a potential increase in SARS-CoV-2 patients [8] . Furthermore, concern for the well-being of living donors in the kidney transplantation community also played a role in the reduction of living donation kidney transplantation [4] .

Finally, the media coverage of the pandemic and the focus on self-isolation might have dissuaded possible living donors from donation.

Next, we observed that clinical characteristics were not significantly different between kidney transplant recipients who were transplanted during and before the lockdown. It is well known that living donation kidney transplantation is beneficial because it rapidly reduces toxic waste products in patients with end-stage kidney disease and normalizes disturbed water-and electrolyte balance. In line with a decreased portion of living donation kidney transplantation we noticed that the relative fall of plasma creatinine during the first postoperative day was lower during the lockdown period.

Our case-control study showed that medical and clinical outcome in kidney transplant recipients was not affected by lockdown recommendations. These findings could be confirmed in all three transplant groups, i.e., ABO incompatible living donation, ABO compatible living donation, and donation after brain death. In this prospective observational study, selection bias was limited by including controls according to prespecified criteria. J o u r n a l P r e -p r o o f

Although the monthly average number of kidney transplantations did not decrease due to the lockdown, the proportions of living donation decreased across all transplantation centers in Denmark. Living kidney donations are associated with better patient-and graft survival outcome compared to donation after brain death (15) , consequently an un-intended consequence to the restrictions could be an earlier return to dialysis for a higher proportion of those transplanted during the Lockdown. As our results show, this will increase the costs in kidney transplant recipients by almost 300,000 EUR. In addition, kidney transplant during the lockdown recommendations may decrease QALY by approximately 1.9%.

The SARS-CoV-2 pandemic and subsequent lockdown recommendations have strained many aspects of health care. To the best of our knowledge, this is the first report showing that the SARS-CoV-2 lockdown recommendations may affect future QALY and costs in kidney transplant recipients transplanted during the lockdown periods. [14] [15] [16] [17] [18] 15 [13] [14] [15] [16] 15 [14] [15] [16] [17] 20 [17] [18] [19] [20] [21] [22] [23] 25 21 [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] 0.20 0.05 0.01 Table 4 . Mean number of kidney transplantations performed per month in Denmark during and before the lockdown. The lockdown period in Denmark was defined as the second, third and fourth quarter of 2020, as well as the first quarter of 2021 to transplant center and donor type. Data were calculated from freely accessable data, which are provided by Scandiatransplant 

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes

COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium

Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic

An International survey on living kidney donation and transplant practices during the COVID-19 pandemic

Pressemøde 11. marts i Spejlsalen

Notat om reduktion af hospitalsaktivitet ifm COVID-19 [PDF. Danish health authority 2020

Interleukin-8 transcripts in mononuclear cells determine impaired graft function after kidney transplantation

The 82-plex plasma protein signature that predicts increasing inflammation

Expert Group for Covid-19 Collaborators. Clinical characteristics of coronavirus disease 2019 in China

Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation

A new equation to estimate glomerular filtration rate

Scandiatransplant 2021

Danish Society of Nephrology Registry

The Danish Society of Nephrology

Comparison of hemodialysis and peritoneal dialysis--a cost-utility analysis

In Denmark kidney transplantation is more costeffective than dialysis

Tables: Table 1 . Baseline characteristics of kidney transplant recipients who were transplanted during the lockdown period from March 13, 2020, until